Bill SponsorBILLSPONSOR
Bill Sponsor
Politicians
Bills
House Bill 3276
116th Congress(2019-2020)
Fair AMP Act
Introduced
Introduced
Introduced in House on Jun 13, 2019
Overview
Text
Introduced in House 
Jun 13, 2019
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Introduced in House(Jun 13, 2019)
Jun 13, 2019
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Jump To
H. R. 3276 (Introduced-in-House)


116th CONGRESS
1st Session
H. R. 3276


To amend title XIX of the Social Security Act to exclude authorized generic drugs from calculation of the average manufacturer price for purposes of the Medicaid drug rebate program, and for other purposes.

IN THE HOUSE OF REPRESENTATIVES

June 13, 2019

Mr. Kennedy (for himself, Mr. O'Halleran, Mr. Kinzinger, and Mr. Smith of Missouri) introduced the following bill; which was referred to the Committee on Energy and Commerce

A BILL

To amend title XIX of the Social Security Act to exclude authorized generic drugs from calculation of the average manufacturer price for purposes of the Medicaid drug rebate program, and for other purposes.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “Fair and Accurate Medicaid Pricing Act of 2019” or the “Fair AMP Act”.

SEC. 2. Excluding authorized generic drugs from calculation of average manufacturer price under the Medicaid drug rebate program; excluding manufacturers from definition of wholesaler.

(a) In general.—Subparagraph (C) of section 1927(k)(1) of the Social Security Act (42 U.S.C. 1396r–8(k)(1)) is amended—

(1) in the subparagraph heading, by striking “Inclusion” and inserting “Exclusion”;

(2) by striking “a new drug application” and inserting “the manufacturer's new drug application”; and

(3) by striking “inclusive” and inserting “exclusive”.

(b) Excluding manufacturers from definition of wholesaler.—Section 1927(k)(11) of the Social Security Act (42 U.S.C. 1396r–8(k)(11)) is amended—

(1) by striking “manufacturers,”; and

(2) by striking “manufacturer's and”.

(c) Effective date.—The amendments made by this section shall take effect on the first day of the first fiscal quarter that begins after the date of enactment of this Act.